Table 4.
Region | Injected drug | ||
---|---|---|---|
Control | PK11195 | Flumazenil | |
[11C]CB184 uptake (%ID/g) | |||
Olfactory bulb | 1.45 ± 0.03 | 0.92 ± 0.11* | 1.36 ± 0.30 |
Cortex | 0.986 ± 0.073 | 0.594 ± 0.037* | 0.965 ± 0.075 |
Striatum | 0.864 ± 0.135 | 0.616 ± 0.026 | 0.806 ± 0.141 |
Hippocampus | 1.225 ± 0.067 | 0.659 ± 0.099* | 1.087 ± 0.122 |
Thalamus | 0.985 ± 0.042 | 0.625 ± 0.024* | 0.908 ± 0.159 |
Midbrain | 0.965 ± 0.071 | 0.626 ± 0.031* | 0.994 ± 0.228 |
Cerebellum | 1.384 ± 0.091 | 0.729 ± 0.057* | 1.361 ± 0.185 |
Pons | 1.045 ± 0.102 | 0.655 ± 0.045* | 1.003 ± 0.180 |
[11C]CB190 uptake (%ID/g) | |||
Olfactory bulb | 1.434 ± 0.090 | 1.026 ± 0.277* | 1.329 ± 0.183 |
Cortex | 0.838 ± 0.072 | 0.731 ± 0.227 | 0.722 ± 0.080 |
Striatum | 0.715 ± 0.052 | 0.738 ± 0.235 | 0.704 ± 0.115 |
Hippocampus | 0.887 ± 0.171 | 0.763 ± 0.134 | 0.643 ± 0.083 |
Thalamus | 0.761 ± 0.084 | 0.702 ± 0.220 | 0.718 ± 0.097 |
Midbrain | 0.950 ± 0.062 | 0.781 ± 0.214 | 0.830 ± 0.313 |
Cerebellum | 1.363 ± 0.046 | 0.849 ± 0.232* | 1.223 ± 0.275 |
Pons | 0.890 ± 0.076 | 0.682 ± 0.199 | 0.793 ± 0.122 |
[11C](R)-PK11195 uptake (%ID/g) | |||
Olfactory bulb | 1.129 ± 0.107 | 0.481 ± 0.240* | 1.015 ± 0.218 |
Cortex | 0.626 ± 0.191 | 0.409 ± 0.112 | 0.606 ± 0.048 |
Striatum | 0.507 ± 0.090 | 0.308 ± 0.089 | 0.634 ± 0.205 |
Hippocampus | 0.730 ± 0.225 | 0.390 ± 0.054 | 0.746 ± 0.248 |
Thalamus | 0.578 ± 0.297 | 0.431 ± 0.205 | 0.456 ± 0.068 |
Midbrain | 0.610 ± 0.056 | 0.359 ± 0.052* | 0.648 ± 0.134 |
Cerebellum | 1.230 ± 0.243 | 0.389 ± 0.025* | 1.171 ± 0.222 |
Pons | 1.129 ± 0.107 | 0.481 ± 0.240 | 1.015 ± 0.218 |
Data represent mean ± SD of four animals. Blocking drugs were intravenously injected 1 min prior to the tracer administration. Data were analyzed 1-way ANOVA with Bonferroni’s correction. Differences were considered significant at a p value less than 0.0167 (*)